|Application ||IHC, EIA|
|Immunogen||Synthetic human Uroguanylin (a.a. 1-8) circulating form (FKTLRTIA).|
|Target/Specificity||Human Uroguanylin (a.a. 1-8) circulating form.|
|Storage||Store lyophilized product at 2-8°C. After reconstitution, aliquot and store at -20°C. Avoid multiple freeze/thaw cycles.|
|Precautions||Rabbit Antibody to Human Uroguanylin is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The references listed below are for research purposes only:1. Hess, R., et al., (1995), “GCAP-II: isolation and characterization of the circulating form of human uroguanylin”, FEBS Lett., 374(1): 34-38.2. Magert, H-J., et al., (1998), “Uroguanylin: Gene structure, expression, processing as a peptide hormone, and co-storage with somatostatin in gastrointestinal D-cells” Regul. Pept., 73(3): 165-176.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.